NASDAQ: CELU
Celularity Inc Stock Ownership - Who owns Celularity?

Insider buying vs selling

Have Celularity Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David C. BeersChief Financial Officer2025-04-13360$1.64
$590.40Sell
Stephen BrigidoPres. Functional Regeneration2025-04-13268$1.64
$439.52Sell
John R. HainesSenior Exec Vice President2025-04-13577$1.64
$946.28Sell
Robert J. HaririChief Executive Officer2025-04-131,154$1.64
$1.89kSell
Robert J. HaririChief Executive Officer2025-04-131,154$1.64
$1.89kSell

1 of 1

CELU insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CELU insiders and whales buy or sell their stock.

CELU Shareholders

What type of owners hold Celularity Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kok Thay Lim128.49%36,400,939$48.78MInsider
Dragasac Ltd106.12%30,062,778$40.28MInsider
Starr International Co Inc53.94%15,281,389$20.48MInsider
Sorrento Therapeutics Inc17.83%5,050,427$6.77MInsider
Robert J. Hariri10.07%2,851,454$3.82MInsider
Jay R. Bloom6.22%1,761,253$2.36MInsider
Adrian Kilcoyne3.96%1,122,238$1.50MInsider
John Sculley3.55%1,004,660$1.35MInsider
Dean C. Kehler2.82%797,858$1.07MInsider
C V Starr Co Inc2.70%764,069$1.02MInstitution

1 of 3

CELU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CELU2.23%97.77%Net Selling
CYPH14.73%85.27%Net SellingNet Selling
PSTV8.05%17.39%Net Buying
TELO6.61%24.95%
LSTA0.81%99.19%Net SellingNet Selling

Celularity Stock Ownership FAQ

Who owns Celularity?

Celularity (NASDAQ: CELU) is owned by 7.81% institutional shareholders, 342.85% Celularity insiders, and 0.00% retail investors. Kok Thay Lim is the largest individual Celularity shareholder, owning 36.40M shares representing 128.49% of the company. Kok Thay Lim's Celularity shares are currently valued at $49.14M.

If you're new to stock investing, here's how to buy Celularity stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.